BVA decisions by condition
Dermatophytosis (ringworm): BVA grant rates and what wins
From 2017 to 2026, the Board of Veterans' Appeals decided a dermatophytosis (ringworm) issue in 7,272 decisions. It granted the dermatophytosis (ringworm) issue in 15.9% of them, below the 19.4% grant rate for all conditions, denied it in 29.6%, and remanded it in 52.5%. Counting only decisions on the merits (granted or denied), 34.9% were granted.
Decisions
7,272
2017–2026
Granted
15.9%
All conditions: 19.4%
Granted on the merits
34.9%
Granted ÷ (granted + denied)
Remanded
52.5%
Denied: 29.6%
Dermatophytosis (ringworm) outcomes by year
| Year | Decisions | Granted | Denied | Remanded |
|---|---|---|---|---|
| 2017 | 601 | 12.6% | 30.4% | 45.1% |
| 2018 | 895 | 13.2% | 30.2% | 53.1% |
| 2019 | 921 | 14.4% | 30.8% | 54.4% |
| 2020 | 850 | 14.4% | 31.4% | 53.5% |
| 2021 | 716 | 14.5% | 28.5% | 56.1% |
| 2022 | 722 | 18.1% | 20.2% | 60.8% |
| 2023 | 769 | 16.6% | 24.2% | 57.9% |
| 2024 | 780 | 15.9% | 30.0% | 52.6% |
| 2025 | 744 | 20.6% | 38.4% | 41.4% |
| 2026 | 274 | 24.1% | 33.9% | 40.5% |
Evidence in granted and denied dermatophytosis (ringworm) decisions
For each kind of supporting evidence: how often the Board granted the dermatophytosis (ringworm) issue on the merits when the decision mentioned it, compared with decisions that did not. These are associations, not causes, and evidence is recorded per decision, not per issue.
| In the record | Decisions | Granted when present | When absent | Difference |
|---|---|---|---|---|
| Positive nexus opinion | 896 | 64.1% | 28.6% | +35.5 pts |
| Favorable VA exam | 769 | 60.8% | 29.9% | +30.8 pts |
| Buddy statement | 231 | 58.0% | 34.1% | +23.9 pts |
| Treating physician opinion | 272 | 55.1% | 33.9% | +21.2 pts |
| Combat service | 529 | 50.2% | 33.5% | +16.7 pts |
| Private medical opinion | 1,729 | 44.7% | 31.2% | +13.5 pts |
| Lay statement | 5,894 | 36.1% | 27.4% | +8.7 pts |
| Claimed as secondary | 447 | 40.4% | 34.7% | +5.7 pts |
- The Board applied the benefit-of-the-doubt rule (38 CFR 3.102) in 75.0% of the decisions that granted dermatophytosis (ringworm).
- The Board found the veteran's statements credible in 58.3% of grants and 15.0% of denials.
Negative evidence in the record
An unfavorable exam or a negative nexus opinion often sits in the same record as favorable evidence, and the Board weighs them against each other. So these rows show how often dermatophytosis (ringworm) was still granted when the record contained the negative item, not that the item helped.
| In the record | Decisions | Granted when present | When absent | Difference |
|---|---|---|---|---|
| Negative nexus opinion | 3,324 | 34.9% | 34.9% | −0.0 pts |
| Unfavorable VA exam | 5,145 | 32.9% | 43.0% | −10.1 pts |
Why the Board granted or denied dermatophytosis (ringworm)
Most common reasons in grants
- Current diagnosis established202
- Continuity of symptomatology since service21
- Criteria for service connection met21
- Service records negative or silent13
- Evidence evenly balanced11
- In-service treatment documented10
- Service connection established9
- New and material evidence received8
Most common reasons in denials
- No current diagnosis296
- Preponderance of the evidence against the claim199
- Service records negative or silent173
- VA examiner: less likely than not related to service152
- Current diagnosis established151
- No in-service complaints, treatment or diagnosis134
- Criteria for compensable rating not met59
- No systemic therapy required48
Numbers are decisions that gave the reason. Reasons are short phrases extracted by AI from each decision; common wordings of the same reason are grouped. Benefit of the doubt is reported above.
Recent dermatophytosis (ringworm) decisions
Granted
Reduction of rating improper as disability had been rated 10% for over five years.; Evidence did not demonstrate sustained improvement in ability to function.; August 2024 VA exam noted progression/worsening; Veteran reported persistent pain.; November 2024 private exam noted thick, deformed toenails.
Reported onset during active-duty service; Credible lay statements regarding onset and continuation; Approximate balance of evidence, doubt resolved in favor
July 1993 service treatment record notes diagnosis and treatment for PFB; Veteran's testimony at November 2024 hearing is credible; Credible reports of continuity of symptoms; Benefit of the doubt resolved in Veteran's favor
Denied
No competent evidence of current disability; PA-C's letter noted self-report but lacked diagnosis or nexus; No VA examination triggered due to lack of competent evidence
No competent evidence of current diagnosis.; Contradictory evidence regarding diagnosis (VA exam negative).; Evidence persuasively weighs against service connection.
Evidence prior to March 6, 2023, did not meet criteria for compensable rating.; Treatment prior to March 6, 2023, did not involve systemic therapy required for higher rating.; PFB evaluated under DC 7813, General Rating Formula for the Skin.
Rules that apply to dermatophytosis (ringworm) claims
- 38 CFR 3.303
Principles of service connection
Read it in VA Law Explorer - 38 CFR 3.310
Secondary service connection and aggravation
Read it in VA Law Explorer - 38 CFR 3.102
Reasonable doubt (benefit of the doubt)
Read it in VA Law Explorer
Research your dermatophytosis (ringworm) case
Narrow by year, judge, evidence or secondary condition, read the decisions, and export a research memo.
How these numbers are calculated
- Rates count decisions in which the Board decided a dermatophytosis (ringworm) issue, by the outcome of that issue. Other issues in the same decision can have different outcomes.
- “Granted on the merits” leaves out remands and dismissals. “All conditions” is the grant share across every condition issue in the data.
- The data comes from CaseScribe's AI extraction of public BVA decisions (2017–2026) and can contain errors. It is updated automatically as new decisions are added.